1 follower
Aura Biosciences is developing a new class of therapies to target and destroy cancer cells selectively, while leaving surrounding tissue unharmed – an approach they call molecular surgery.
Elisabet de los Pinos
Immunome
2 followers
Day One Biopharmaceuticals
1 follower
Othram
1 follower
Thermo Fisher Scientific
165 followers
Gilead Sciences
128 followers
Biogen
114 followers
Regeneron
93 followers
Alexion Pharmaceuticals
34 followers
BeiGene
20 followers
Bio-Rad Laboratories
20 followers
Kura Oncology
17 followers
Explore companies